Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Klotho Neurosciences Inc (KLTO)

Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Beyond Weight Loss: The "Cellular Reset" That Could Create the Next Biotech Supercycle BayStreet.ca - Tue Dec 16, 8:10AM CST

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that metabolic dysfunction...

LGVN : 0.5894 (+6.62%)
AVAI : 0.3190 (+0.41%)
BIOA : 12.61 (+0.76%)
GAA : 32.57 (+0.28%)
DNLI : 16.91 (-0.65%)
MAPT : 0.0003 (unch)
KLTO : 0.3788 (-2.87%)
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award PR Newswire - Fri Nov 7, 9:03AM CST

NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"), a U.S.-based biogenetics company, announces it has been selected as winner of the Fifth...

KLTO : 0.3788 (-2.87%)
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston PR Newswire - Thu Oct 16, 7:00AM CDT

NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") a U.S.-based biogenetics company, announces that members of its leadership team will...

KLTO : 0.3788 (-2.87%)
Klotho Neurosciences Announces Expiration of Letter of Intent PR Newswire - Tue Oct 7, 5:20PM CDT

NEW YORK , Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed to expire...

KLTO : 0.3788 (-2.87%)
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership PR Newswire - Tue Sep 30, 7:30AM CDT

NEW YORK and PALO ALTO, Calif. , Sept. 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho" or "the Company") today announced it has signed a Letter of...

KLTO : 0.3788 (-2.87%)
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar PR Newswire - Mon Sep 8, 7:00AM CDT

NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative...

KLTO : 0.3788 (-2.87%)
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market PR Newswire - Mon Aug 18, 7:30AM CDT

Key partnerships, regulatory  progress, manufacturing advancements, along with significant capital infusion accelerate the development of Klotho-based therapeutics

KLTO : 0.3788 (-2.87%)
Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology PR Newswire - Tue Aug 12, 5:00AM CDT

NEW YORK , Aug. 12, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc . (Nasdaq: KLTO ), announces that it signed a binding agreement to initiate manufacturing and development of...

KLTO : 0.3788 (-2.87%)
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology PR Newswire - Fri Jul 25, 8:05PM CDT

Company to Pursue Technologies to Improve Brain Function, Muscle Strength, Bone Health, and Other Longevity Indicators

KLTO : 0.3788 (-2.87%)
Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology PR Newswire - Thu Jul 24, 12:30PM CDT

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity Indicators

KLTO : 0.3788 (-2.87%)

Barchart Exclusives

Cathie Wood Keeps Buying the Dip in CoreWeave Stock. Should You? Barchart - 25 minutes ago
Down almost 62% from all-time highs, Cathie Wood continues to purchase shares of CoreWeave in December 2025, as the AI infrastructure company continues to grow rapidly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot